Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and Carcinoma, Non-Small Cell Lung

fulvestrant has been researched along with Carcinoma, Non-Small Cell Lung in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.11)29.6817
2010's13 (72.22)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Szymaszek, Ż; Twardowska, M; Uram, Ł; Walczak, M; Wołowiec, S; Wróbel, K1
Almotlak, AA; Farooqui, M; Siegfried, JM1
Ai, B; Cao, X; Fan, S; Li, D; Li, L; Liao, Y; Qiu, W1
Dacic, S; Farooqui, M; Rothenberger, NJ; Siegfried, JM; Stabile, LP1
Fan, S; Fu, X; Liao, Y; Liu, C; Wang, J; Xiong, J; Zhou, S; Zou, M1
Adams, B; Brennan, M; Dacic, S; Davenport, S; Dubinett, SM; Elashoff, D; Elashoff, RM; Garon, EB; Grogan, T; Hu, EH; Marquez-Garban, DC; Parikh, RJ; Park, DJ; Patel, R; Pietras, RJ; Press, MF; Reckamp, KL; Sadeghi, S; Siegfried, JM; Slamon, DJ; Stabile, LP; Valdes, Y; Wang, HJ; Young, PA1
Chen, Q; Li, Q; Liu, J; Qian, X; Shen, H; Shi, Z; Shu, Y; Wang, L; Wang, R; Xu, R; Xu, T; Zheng, J1
Siegfried, JM1
Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M1
An, T; Bai, H; Ding, X; Duan, J; Li, Z; Liu, Z; Shen, Z; Sun, Y; Wang, J; Wang, S; Wang, Y; Wang, Z; Wu, M; Zhao, J; Zhong, J; Zhuo, M1
Brosseau, S; Naltet, C; Oulkhouir, Y; Zalcman, G1
Abe, K; Akahira, J; Evans, DB; Hata, S; Iida, S; Kondo, T; Miki, Y; Mori, K; Niikawa, H; Sasano, H; Suzuki, S; Suzuki, T; Yamada-Okabe, H1
Gubish, CT; Henry, C; Rothstein, ME; Siegfried, JM; Stabile, LP1
Abe, K; Miki, Y; Niikawa, H; Sasano, H; Verma, MK1
Gao, W; Guo, R; Shen, H; Shu, Y; Sun, J; Xu, R1
Dering, J; Desai, AJ; Dubinett, SM; Finn, RS; Garon, EB; Hosmer, W; Kamranpour, N; Márquez-Garbán, DC; Pietras, RJ; Pitts, S; Slamon, DJ; von Euw, EM1
Grandis, JR; Gubish, CT; Lyker, JS; Siegfried, JM; Stabile, LP; Zhang, W1
Hershberger, PA; Kanterewicz, B; Land, S; Nichols, M; Siegfried, JM; Vasquez, AC1

Reviews

2 review(s) available for fulvestrant and Carcinoma, Non-Small Cell Lung

ArticleYear
Smoking out reproductive hormone actions in lung cancer.
    Molecular cancer research : MCR, 2014, Volume: 12, Issue:1

    Topics: Aromatase; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Lung; Lung Neoplasms; Male; Smoking; Testosterone

2014
[Resistances to targeted therapies and strategy for following therapeutic lines in metastatic NSCLC].
    Bulletin du cancer, 2015, Volume: 102, Issue:6 Suppl 1

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cetuximab; Disease-Free Survival; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Fulvestrant; Humans; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Protein Kinase Inhibitors; Translocation, Genetic

2015

Trials

1 trial(s) available for fulvestrant and Carcinoma, Non-Small Cell Lung

ArticleYear
Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2018, Volume: 123

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Fulvestrant; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Analysis; Treatment Outcome

2018

Other Studies

15 other study(ies) available for fulvestrant and Carcinoma, Non-Small Cell Lung

ArticleYear
Exploring the Potential of Lapatinib, Fulvestrant, and Paclitaxel Conjugated with Glycidylated PAMAM G4 Dendrimers for Cancer and Parasite Treatment.
    Molecules (Basel, Switzerland), 2023, Aug-30, Volume: 28, Issue:17

    Topics: Animals; Caenorhabditis elegans; Carcinoma, Non-Small-Cell Lung; Dendrimers; Fulvestrant; Glioma; Humans; Lapatinib; Lung Neoplasms; Paclitaxel; Parasites

2023
Inhibiting Pathways Predicted From a Steroid Hormone Gene Signature Yields Synergistic Antitumor Effects in NSCLC.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2020, Volume: 15, Issue:1

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Fulvestrant; Lung Neoplasms; Mice; Neoplasm Recurrence, Local; Signal Transduction; Xenograft Model Antitumor Assays

2020
Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:11

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cell Movement; Estrogen Receptor Antagonists; Estrogen Receptor beta; Female; Fulvestrant; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Sulfonamides; Toll-Like Receptor 4

2020
Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Oncotarget, 2017, Apr-11, Volume: 8, Issue:15

    Topics: Animals; Antineoplastic Agents, Hormonal; Benzamides; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Estradiol; Estrogens; Female; Fibroblast Growth Factors; Fulvestrant; Humans; Ligands; Lung Neoplasms; Mice; Neoplastic Stem Cells; Piperazines; Protein Binding; Pyrazoles; Receptors, Estrogen; Receptors, Fibroblast Growth Factor; Signal Transduction; Xenograft Model Antitumor Assays

2017
G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
    Oncology research, 2019, Feb-21, Volume: 27, Issue:3

    Topics: A549 Cells; Adenocarcinoma; Animals; Benzodioxoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; Humans; Lung Neoplasms; Mice; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Urethane

2019
Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Estradiol; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; MicroRNAs; Quinazolines; Transfection; Up-Regulation

2014
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:4

    Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays

2015
ERβ localization influenced outcomes of EGFR-TKI treatment in NSCLC patients with EGFR mutations.
    Scientific reports, 2015, Jun-22, Volume: 5

    Topics: 3T3 Cells; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Asian People; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; China; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Estrogen Receptor Antagonists; Estrogen Receptor beta; Female; Fulvestrant; Gefitinib; HeLa Cells; Humans; Lung Neoplasms; Male; MCF-7 Cells; Mice; Middle Aged; Protein Kinase Inhibitors; Quinazolines

2015
Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment.
    Cancer research, 2010, Aug-15, Volume: 70, Issue:16

    Topics: Aged; Androgens; Aromatase; Carcinoma, Non-Small-Cell Lung; Cell Communication; Cell Line, Tumor; Coculture Techniques; Estradiol; Estrogens; Female; Fulvestrant; Humans; Immunohistochemistry; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Oncostatin M; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Tumor Necrosis Factor-alpha

2010
Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Synergism; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fluorescent Antibody Technique; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, SCID; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-3

2012
Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.
    Expert opinion on therapeutic targets, 2012, Volume: 16 Suppl 1

    Topics: Aromatase; Biomarkers, Tumor; Butadienes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Immunohistochemistry; Lung Neoplasms; Nitriles

2012
Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2012, Volume: 66, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Estradiol; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Receptors, Estrogen; Signal Transduction; Up-Regulation

2012
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:3

    Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Synergism; ErbB Receptors; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

2013
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
    Cancer research, 2005, Feb-15, Volume: 65, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 3; Quinazolines; Receptors, Estrogen; Xenograft Model Antitumor Assays

2005
Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
    Cancer research, 2005, Feb-15, Volume: 65, Issue:4

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lung Neoplasms; Nuclear Receptor Coactivator 2; Receptors, Estrogen; Transcription Factors

2005